Bivalirudin in Late PCI for Oatients With STEMI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.
Also called NCT04185077
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,200 participants
- Registry
-
NCT04185077
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04185077. Randomized; no masking; primary purpose treatment. Start 2019-11-30 (anticipated); primary completion 2020-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bivalirudin in Late PCI for Oatients With STEMI
- Acronym
- BETTER
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug)
- Bivalirudin
- Intervention (Drug)
- Heparin
- Lead sponsor
- Second Xiangya Hospital of Central South University
Record details
- Record id
cardio:ct-nct04185077- Content hash
41bd5b809a1f69c500cffad17fb6b53a6d67521cd08da033f923389453839333